EMEA-002521-PIP01-18
Key facts
| Active substance |
Botulinum toxin type A
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0281/2019
|
| PIP number |
EMEA-002521-PIP01-18
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of skin wrinkling
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|